Part definitions

As used in this part: (1) "Anti-rejection drug" means a prescription drug that suppresses the immune system to prevent or reverse rejection of a transplanted organ; (2) "Board" means the board of pharmacy; (3) "Cancer drug" means a prescription drug that is used to treat: (A) Cancer or the side effects of cancer; or (B) The side effects of a prescription drug that is used to treat cancer or the side effects of cancer; (4) "Controlled substance" has the same meaning as defined in § 39-17-402 ; (5) "Department" means the department of health; (6) "Donor" means any of the following that donates prescription drugs to a repository program approved pursuant to this part: (A) A person; (B) A pharmacy; (C) A medical facility; (D) A drug manufacturer or wholesaler licensed by the board; or (E) A prison or government entity federally authorized to possess prescription drugs with a license or permit in good standing in the state in which the entity is located; (7) "Eligible individual" means an indigent, an uninsured person, or an underinsured person who meets the criteria for eligibility pursuant to this part; (8) "Indigent" means a person with an income that is below six hundred percent (600%) of the federal poverty level as defined by the most recently revised poverty income guidelines published by the United States department of health and human services; (9) "Medical facility" means: (A) A physician's office; (B) A hospital; (C) A health clinic; (D) A nonprofit health clinic, including a federally qualified health center as defined in 42 U.S.C. § 1396d(l)(2)(B) ; a rural health clinic, as defined in 42 U.S.C. § 1396d(l)(1) ; and a nonprofit health clinic that provides medical care to patients who are indigent, uninsured, or underinsured; (E) A free clinic as defined in § 63-6-703 ; (F) A charitable organization as defined in § 48-101-501 ; or (G) A nursing home as defined in § 68-11-201 ; (10) "Pharmacy" means a pharmacy as defined in § 63-10-204 ; (11) "Prescription drug": (A) Has the same meaning as defined in § 63-10-204 ; (B) Includes, but is not limited to, cancer drugs and anti-rejection drugs; and (C) Does not include: (i) Controlled substances; or (ii) Drugs covered by the risk evaluation and mitigation strategy program of the United States food and drug administration; (12) "Repository" means a pharmacy that: (A) Has a license or permit in good standing with the board; and (B) Meets the requirements established by § 63-10-503 ; (13) "Supplies" means the supplies necessary to administer the prescription drugs donated pursuant to this part; and (14) "Unopened tamper-evident packaging" has the same meaning as defined in United States Pharmacopeia (USP) General Chapter 659, Packaging and Storage Requirements. Added by 2023 Tenn. Acts, ch. 200, s 1, eff. 1/1/2024. As used in this part: (1) "Anti-rejection drug" means a prescription drug that suppresses the immune system to prevent or reverse rejection of a transplanted organ; (2) "Board" means the board of pharmacy; (3) "Cancer drug" means a prescription drug that is used to treat: (A) Cancer or the side effects of cancer; or (B) The side effects of a prescription drug that is used to treat cancer or the side effects of cancer; (A) Cancer or the side effects of cancer; or (B) The side effects of a prescription drug that is used to treat cancer or the side effects of cancer; (4) "Controlled substance" has the same meaning as defined in § 39-17-402 ; (5) "Department" means the department of health; effects of cancer; or (B) The side effects of a prescription drug that is used to treat cancer or the side effects of cancer; (A) Cancer or the side effects of cancer; or (B) The side effects of a prescription drug that is used to treat cancer or the side effects of cancer; (4) "Controlled substance" has the same meaning as defined in § 39-17-402 ; (5) "Department" means the department of health; (6) "Donor" means any of the following that donates prescription drugs to a repository program approved pursuant to this part: (A) A person; (B) A pharmacy; (C) A medical facility; (D) A drug manufacturer or wholesaler licensed by the board; or (E) A prison or government entity federally authorized to possess prescription drugs with a license or permit in good standing in the state in which the entity is located; (A) A person; (B) A pharmacy; (C) A medical facility; (D) A drug manufacturer or wholesaler licensed by the board; or (E) A prison or government entity federally authorized to possess prescription drugs with a license or permit in good standing in the state in which the entity is located; (7) "Eligible individual" means an indigent, an uninsured person, or an underinsured person who meets the criteria for eligibility pursuant to this part; (8) "Indigent" means a person with an income that is below six hundred percent (600%) of the federal poverty level as defined by the most recently revised poverty income guidelines published by the United States department of health and human services; (9) "Medical facility" means: (A) A physician's office; (B) A hospital; (C) A health clinic; (D) A nonprofit health clinic, including a federally qualified health center as defined in 42 U.S.C. § 1396d(l)(2)(B) ; a rural health clinic, as defined in 42 U.S.C. § 1396d(l)(1) ; and a nonprofit health clinic that provides medical care to patients who are indigent, uninsured, or underinsured; (E) A free clinic as defined in § 63-6-703 ; (F) A charitable organization as defined in § 48-101-501 ; or (G) A nursing home as defined in § 68-11-201 ; (A) A physician's office; (B) A hospital; (C) A health clinic; (D) A nonprofit health clinic, including a federally qualified health center as defined in 42 U.S.C. § 1396d(l)(2)(B) ; a rural health clinic, as defined in 42 U.S.C. § 1396d(l)(1) ; and a nonprofit health clinic that provides medical care to patients who are indigent, uninsured, or underinsured; (E) A free clinic as defined in § 63-6-703 ; (F) A charitable organization as defined in § 48-101-501 ; or (G) A nursing home as defined in § 68-11-201 ; (10) "Pharmacy" means a pharmacy as defined in § 63-10-204 ; (11) "Prescription drug": (A) Has the same meaning as defined in § 63-10-204 ; (B) Includes, but is not limited to, cancer drugs and anti-rejection drugs; and (C) Does not include: (i) Controlled substances; or (ii) Drugs covered by the risk evaluation and mitigation strategy program of the United States food and drug administration; (A) Has the same meaning as defined in § 63-10-204 ; (B) Includes, but is not limited to, cancer drugs and anti-rejection drugs; and (C) Does not include: (i) Controlled substances; or (ii) Drugs covered by the risk evaluation and mitigation strategy program of the United States food and drug administration; luation and mitigation strategy program of the United States food and drug administration; (A) Has the same meaning as defined in § 63-10-204 ; (B) Includes, but is not limited to, cancer drugs and anti-rejection drugs; and (C) Does not include: (i) Controlled substances; or (ii) Drugs covered by the risk evaluation and mitigation strategy program of the United States food and drug administration; (i) Controlled substances; or (ii) Drugs covered by the risk evaluation and mitigation strategy program of the United States food and drug administration; (12) "Repository" means a pharmacy that: (A) Has a license or permit in good standing with the board; and (B) Meets the requirements established by § 63-10-503 ; (A) Has a license or permit in good standing with the board; and (B) Meets the requirements established by § 63-10-503 ; (13) "Supplies" means the supplies necessary to administer the prescription drugs donated pursuant to this part; and (14) "Unopened tamper-evident packaging" has the same meaning as defined in United States Pharmacopeia (USP) General Chapter 659, Packaging and Storage Requirements. Added by 2023 Tenn. Acts, ch. 200, s 1, eff. 1/1/2024.